Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that eyelash trichomegaly, which is the abnormal growth of eyelashes, can be present from birth, caused by diseases, or result from certain medications.

Permanent hair loss from cicatricial alopecia is treated by reducing inflammation and managing symptoms, but regrowth in scarred areas is unlikely.

Methotrexate for rheumatoid arthritis often causes side effects like diarrhea, fatigue, and hair loss, especially at higher doses.

A woman developed psoriasis after taking certolizumab pegol, improving after stopping the drug and starting other treatments.

Hydroxychloroquine showed some potential, but overall, the three drugs had limited success in treating lupus in dogs.

Shrinking of oil glands in the skin is a key sign of hair loss linked to TNF inhibitor drugs and may improve if the treatment is stopped.

There is no standard treatment for the rare Cronkhite–Canada syndrome, which can be fatal and lead to cancer.

Most treatments for spondyloarthritis are safe, but monitoring and careful selection based on patient risks are important.

Using systemic drugs as creams for skin conditions shows promise, but more research is needed to confirm their effectiveness and safety.

People with Inflammatory Bowel Disease often lose hair due to stress, medication side effects, or lack of nutrients, and treatment depends on the specific cause.

The document concludes that oral finasteride and topical minoxidil are effective for genetic hair loss, while other treatments for different types of hair loss show promise but need more research.

The article suggests that targeting specific immune pathways could help control and treat the skin disease hidradenitis suppurativa.

The new FDA labeling rules provide more detailed drug safety information for pregnant and breastfeeding women, but more data is needed on the risks of many dermatologic drugs.

Effective treatments for severe alopecia areata are still lacking.

Adalimumab helped control a child's severe eye disease when other treatments failed.

Lupus treatment requires a combination of drugs and therapies, with research needed for new options.

Immune checkpoint inhibitors can cause skin issues but are linked to better cancer outcomes.

ACTH may be an effective first-line treatment for acute calcium pyrophosphate crystal arthritis.

Gamma delta T cells in the skin help with healing and defense but can also cause autoimmune issues, and more research is needed to understand how they are activated.

High levels of the protein Flightless I worsen ulcerative colitis symptoms in mice.

Stopping adalimumab and starting methotrexate with topical treatments improved the woman's scalp psoriasis and hair regrew.

A young woman had a rare skin reaction to a medication for her joint disease, and a combination therapy improved her condition.

Skin reactions to drugs are common and can be deadly, usually requiring stopping the drug and may be better prevented with genetic testing in the future.

Some treatments can help hair regrowth in alopecia areata, but none offer a cure, and effectiveness varies.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

The document concludes that proper diagnosis and evidence-based treatments are crucial for managing hair diseases, and psychological support for patients is important.

Certain liver diseases respond well to specific treatments and have varying risks for liver cancer.

New targeted therapies for hair loss from alopecia areata show promise, with personalized treatment expected in the future.

Blocking interferon-gamma might help treat various autoimmune diseases.

WNT7A gene expression is higher in early stages of androgenetic alopecia, showing the role of WNT pathway, apoptosis, and inflammation in the disorder.